A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19

NCT04347031 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

320

Enrollment

OTHER_GOV

Sponsor class

Conditions

Pneumonia, Viral
Respiratory Failure

Interventions

DRUG: Mefloquine
DRUG: Hydroxychloroquine
COMBINATION_PRODUCT: Mefloquine + azithromycin + / - tocilizumab
COMBINATION_PRODUCT: Hydroxychloroquine + azithromycin + / - tocilizumab

Sponsor

Burnasyan Federal Medical Biophysical Center